Delivery Order SPE2DB22D9367-SPE2DB25FSZ41
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,561.15 by the Defense Logistics Agency (DLA) on September 15, 2025. The delivery order, which has an ultimate completion date of October 6, 2025, is for the supply of Xolair 300 mg/2 ml auto-injector syringes to support Department of Defense healthcare operations. This award carries no set-aside designation, allowing the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,424.46 by the Defense Logistics Agency on September 11, 2025, for the supply of Xolair 300 mg/2 mL auto-injector units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 2, 2025, and no set-aside designation was applied to this procurement action. This delivery order is issued under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $28.3K by the Defense Logistics Agency's Medical Supply Chain on August 27, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order is scheduled for completion by September 18, 2025, with no set-aside designation applied. The award represents a discrete fulfillment under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,424.44 by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of XOLAIR 150 mg/ml autoinjector medication. The contract carries a firm fixed-price structure with an ultimate completion date of August 28, 2025, and was awarded without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $1,712.23 by the Defense Logistics Agency (DLA) for the supply of Xolair 300 mg/2 ml auto-injector vials. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $13,697.84 by the Defense Logistics Agency on April 24, 2025, for the supply of Xolair 300 mg/2 ml auto-injector medications. The delivery order, which carries no set-aside designation, is scheduled for completion by May 15, 2025, with performance occurring at the company's Park Ridge facility. This award represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency on September 15, 2025, for Xolair 300 mg/2 ml auto-injector pharmaceutical products, with a ceiling value of $1,712.23. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,848.88 by the Defense Logistics Agency (DLA) on September 3, 2025. The contract calls for the delivery of Xolair 150 mg/ml auto-injector medication, with an ultimate completion date of September 24, 2025. No set-aside designation was applied to this award. This delivery order is issued under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,424.46 by the Defense Logistics Agency on April 24, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. The award utilizes a firm fixed-price contract type with no set-aside designation, with an ultimate completion date of May 15, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,277.01 by the Defense Logistics Agency (DLA) on June 18, 2025, with an ultimate completion date of July 11, 2025. The contract covers the supply of Xolair 75 mg/0.5 ml auto-injector units and is structured as a firm fixed-price delivery order with no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FSZ41Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $10,273.38 by the Defense Logistics Agency on August 26, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. The contract carries no set-aside designation and is scheduled for completion by September 17, 2025, with performance taking place at the contractor's Park Ridge facility. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The DLA SPE2DB contract vehicle enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure multiple delivery orders across diverse medical categories ranging from specialty injections to oncology treatments and auto-injectors. This particular order for Xolair, a monoclonal antibody used in asthma and allergic conditions treatment, reflects the company's continued role in delivering specialized pharmaceutical products to military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 8/26/25 |